{"version":"1.0","type":"link","title":"Real-World Clinical Outcomes and Treatment Patterns in Advanced/Metastatic EGFR-Mutant NSCLC After Progression on First-Line Osimertinib for French Patients.","author_name":"Girard N 외","author_url":"https://prs-insight.online/author/Girard%20N","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/94801","thumbnail_width":1200,"thumbnail_height":630}